C
Cns Pharmaceuticals (CNSP)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Cns Pharmaceuticals (CNSP)
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candi... Read more
- USD1.08
- USD1.08
- USD0.99
- USD800.00
- -19.20%
- --
- 39.38k
- 200.55k
- 3M
- 0.77
- -99.80%
Stock News
3 hours ago
Royal Caribbean boosts profit outlook as record bookings highlight cruise appeal
MarketWatch
4 hours ago
Honeywell shares jump on strong earnings. Here is Jim Cramer's advice on the stock
CNBC
4 hours ago
United Airlines grows highest-end Polaris airport lounge by 50% in battle for wealthy customers
CNBC
4 hours ago
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
